DANIELLE SOOKOOR: Open Payments
NPI 1811311905 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$254 in 12 payments from 7 companies in 2025. Trend: 2023 $195 · 2024 $186 · 2025 $254
Food & beverage: $254
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $68 |
| Lilly USA, LLC | 3 | $64 |
| Dexcom, Inc. | 2 | $37 |
| Corcept Therapeutics | 1 | $26 |
| GlaxoSmithKline, LLC. | 1 | $23 |
| Abbott Laboratories | 1 | $21 |
| Currax Pharmaceuticals LLC | 1 | $14 |
Products named: Wegovy, MOUNJARO, Dexcom G6 Transmitter, Korlym, SHINGRIX, FREESTYLE LIBRE 3, CONTRAVE.
Industry payments across TX — which companies pay providers there.
